Icon

DEXILANT SOLUTAB (nda208056)- (30MG)

DEXLANSOPRAZOLE TAKEDA PHARMS USA
30MG
No No
2029-Mar-10 Expired
None None
None No
DEXILANT SoluTab delayed-release orally disintegrating tablets (DEXILANT SoluTab) are indicated in patients 12 years of age and older for: • Maintenance of healed EE and relief of heartburn. • Treatment of symptomatic non-erosive GERD.
0 0 0
Total Other Developers None
Drugs with Suitability No
30MG ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.